Obesity and diabetes are severe and growing issues in CEE countries. Consequently, weight management was the 3rd fastest-growing CHC category in the region in the past 5 years. Currently available treatments do not meet the demand of European consumers, who are frequently looking for new solutions to address the issue.
Metabolic syndrome is a cluster of common abnormalities, including insulin resistance, impaired glucose tolerance, abdominal obesity, reduced high-density lipoprotein (HDL)-cholesterol levels, elevated triglycerides, and hypertension. Incidence is increasing in line with the number of people who are overweight or obese.
We have prepared a presentation with collected market data.
- the global weight management category is projected to grow faster than OTC and VDS categories in the future years (Euromonitor)
- weight management was the 3rd fastest-growing consumer healthcare category in the CEE region in the past 5 years and it grew by a CAGR of 3,4% from 2018-22 (Euromonitor)
- the heart health dietary supplement category (also relevant to metabolic syndrome) grew faster than the total Eastern European supplement average in the past 5 years (Euromonitor)
- over 25% of European consumers are dissatisfied with current solutions for obesity/weight management and over 50% are frequently looking for new ways to address their issues (Euromonitor Consumer Survey)
Find out how to address this opportunity with clinically supported ingredients by downloading our portfolio or requesting more information below.